Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:778-783
Published online before print January 28, 2008, doi: 10.1161/HYPERTENSIONAHA.107.100370
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/3/778    most recent
HYPERTENSIONAHA.107.100370v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pereira, T. V.
Right arrow Articles by Krieger, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pereira, T. V.
Right arrow Articles by Krieger, J. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Genomics
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease

(Hypertension. 2008;51:778.)
© 2008 American Heart Association, Inc.


Original Articles

Meta-Analysis of the Association of 4 Angiotensinogen Polymorphisms With Essential Hypertension

A Role Beyond M235T?

Tiago Veiga Pereira; Ane C.F. Nunes; Martina Rudnicki; Yoshiji Yamada; Alexandre Costa Pereira; José E. Krieger

From the Heart Institute (InCor) (T.V.P., A.C.P., J.E.K.) and Clinical and Toxicological Analysis Department (M.R.), Faculty of Pharmaceutical Sciences, University of Sao Paulo Medical School, São Paulo, Brazil; Division of Nephrology (A.C.F.N.), São Paulo University Medical School, University of São Paulo, São Paulo, Brazil; and the Department of Human Functional Genomics (Y.Y.), Life Science Research Center, Mie University, Mie, Japan.

Correspondence to José E. Krieger, InCor, Laboratório de Genética e Cardiologia Molecular/LIM 13, Av Dr Enéas Carvalho Aguiar, 44, São Paulo–SP, CEP-05403-000, Brazil. E-mail krieger{at}incor.usp.br

Angiotensinogen (AGT) gene polymorphisms have been linked to increased risk of hypertension, but the data remain controversial. In this study we review the most commonly investigated polymorphisms at the AGT locus (other than M235T) and provide summary estimates regarding their association with essential hypertension, while addressing heterogeneity, as well as publication biases. Data on 26 818 subjects from 46 studies for the 4 most-studied AGT variants (T174M in exon 2 and 3 promoter variants: A-6G, A-20C, and G-217A) were meta-analyzed. Statistically significant associations with hypertension were identified for the T174M (odds ratio [OR]: 1.19; 95% CI: 1.07 to 1.33; P=0.002) and G-217A (OR: 1.37; 95% CI: 1.17 to 1.59; P=0.00006) polymorphisms. A dual but consistent effect was observed for the –20C allele, which was associated with a decreased risk of hypertension in populations of mixed and European ancestries (OR: 0.64; 95% CI: 0.44 to 0.92; P=0.02 and OR: 0.77; 95% CI: 0.65 to 0.91; P=0.003, respectively), but with a 24% increase in the odds of hypertension in Asian subjects (OR: 1.24; 95% CI: 1.04 to 1.48; P=0.02). No association of the A-6G variant with hypertension was detected. Current studies support the notion that single variants at the AGT might modulate the risk of hypertension but indicate caution in interpreting these results because of the putative presence of publication bias and gene-environment interactions.


Key Words: angiotensinogen • hypertension • polymorphism • meta-analysis • T174M • M235T




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Jain, G. Vinukonda, S. N. Fiering, and A. Kumar
A haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1849 - R1857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. D. Sigmund
A growing chain of evidence linking genetic variation in angiotensinogen with essential hypertension: focus on "A haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G," by Jain et al.
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1846 - R1848.
[Full Text] [PDF]